Live Free Live Natural | Josh Mur
Throughout recent years, a number of common and alternative options for cancer treatment have emerged from laboratories worldwide. They range from radiation therapy, stem cells, surgery, and everywhere in between. While the scientific community has made remarkable breakthroughs, we still haven’t pinpointed an absolute cancer cure. (As far as we are told anyway.) Now a new study conducted by a research team at the University of Missouri has revealed very positive results for a completely new type of cancer treatment.
This particular treatment focuses on regulating and destroying cancer cells through manipulation of quorum sensing. Quorum sensing is a method of communication between bacteria through releasing autoinducers (signaling molecules). Bacteria release several different types of autoinducers, each of them containing a specific command to the other cells.
Senthil Kumar, research professor at MU College of Veterinary Medicine, states, “Depending on the type of molecule released, the signal will tell other bacteria to multiply, escape the immune system or even stop spreading. We found that if we introduce the ‘stop spreading’ bacteria molecule to cancer cells, those cells will not only stop spreading; they will begin to die as well.”
Excited yet? It gets better. Human pancreatic cancer cells were used during the trial. According to statistics, pancreatic cancer is one of the most aggressive and ruthless forms, ranking number 4 in leading causes of cancer related deaths in the U.S. By the end of the treatment, as stated above, the growth was interrupted and the cells began to perish.
So what is next?
“At this time, we only are able to treat cancer cells with this molecule in a laboratory setting. We are now working on a better method which will allow us to treat animals with cancer to see if this therapy is truly effective. The early-stage results of this research are promising. If additional studies, including animal studies, are successful then the next step would be translating this application into clinics,” Dr. Kumar says.
Hopefully we will see positive results in the near future! I give my thanks to the researchers behind this study.